Oruka Therapeutics, Inc. ORKA Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- Oruka Therapeutics, Inc. (ORKA) reported effective income tax rate reconciliation, tax credit, research, amount of $527.25K in Q4 2025.
- How has Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
- Oruka Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount decreased by 81.4% year-over-year, from $2.84M to $527.25K.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- This represents the dollar amount of tax benefits derived from research and development tax credits applied against the statutory income tax rate. It highlights the company's ability to reduce its tax liability through innovation-related incentives.